Exchange: NASDAQ·Updated 07:42 PM EDT
INO logo

INO Inovio Pharmaceuticals Inc

$1.25
$0.03
(2.34%)
Today
Closed $1.25
$0.04
(3.20%)
After Hours
EarningsNov 10
Mkt Cap$129.25M
Vol2.39M

About INO

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
31

Bearish Sentiment

How do you feel about INO?

Advertisement|Remove ads.